Biomedicine & pharmacotherapy prevention of pentylenetetrazole-induced kindling and behavioral comorbidities in mice by levetiracetam combined with the GLP-1 agonist liraglutide : involvement of brain antioxidant and BDNF upregulating properties
26, 2026: When Novo Nordisk filed suit against Hims & Hers in early February, the case immediately drew attention as a high-stakes patent fight over semaglutide and what it could mean for the broader multi-billion-dollar market for GLP-1 treatments
These vitamin injections rarely cause any side effects
10.1161/CIRCULATIONAHA.118.038868 60 ZhengS
Younger workers appeared especially influenced by access to these treatments when making career decisions
Translational Psychiatry 5.CrossRefGoogle Scholar Tuesta, LM, Chen, Z, Duncan, A, Fowler, CD, Ishikawa, M, Lee, BR, Liu, XA, Lu, Q, Cameron, M, Hayes, MR and Kamenecka, TM (2017) GLP-1 acts on habenular avoidance circuits to control nicotine intake